A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 18, n. 1, 2017. DOI: 10.7175/fe.v18i1.1312. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1312. Acesso em: 29 oct. 2025.